Source: Annual Congress 2003 - Animal models of lung injury: useful or not?
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Bonniaud, M. Kolb, T. Galt, J. Robertson, C. Robbins, A. B. Roberts, P. J. Margetts, J. Gauldie (Hamilton, Canada; Dijon, France; Wurzburg, Germany; Bethesda). Ageing Smad3 KO mice develop emphysema and are resistant to Transforming growth factor-β1 (TGF-β1) mediated pulmonary fibrosis. Eur Respir J 2003; 22: Suppl. 45, 3327

Member's Comments

No comment yet.

Related content which might interest you: Connective tissue growth factor (CTGF) induces lung fibrosis in otherwise fibrosis-resistant Balb/c mouse in a bleomycin model Source: Eur Respir J 2004; 24: Suppl. 48, 104s Year: 2004 Wnt11 inhibits effects of transforming growth factor-beta1 (TGFbeta1) on lung epithelial phenotype Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Altered expression of the Smad signalling pathway: implications for COPD pathogenesis Source: Eur Respir J 2006; 28: 533-541 Year: 2006 17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice. Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 Metformin attenuates bleomycin-induced pulmonary fibrosis in mice via IGF-1 suppression Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 Development of pulmonary fibrosis in conditional Nedd4-2 deficient mice Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias Year: 2018 Amplified virus infection in a transforming growth factor-beta (TGFB) transgenic mouse model of inflammatory lung disease Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma Source: Eur Respir J 2006; 27: 208-229 Year: 2006 Pleural fibrosis induced by transforming growth factor (TGF)-β1 gene transfer Source: Eur Respir J 2005; 26: Suppl. 49, 100s Year: 2005 Calcium-sensing receptor (CaSR) drives lung ECM remodelling and fibrosis in murine asthma models and in ageing mice Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Late Breaking Abstract - Il24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing the m2 program in macrophages Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Haemophilus influenzae (NTHi) up-regulates acute inflammation in human lung tissue and causes downregulation of transforming growth factor-beta (TGF-beta) – A possible role of NTHi in remodeling processes in human lung tissue Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Modulation of fibroblast phenotype in idiopathic pulmonary fibrosis: Role of Nrf2 Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Transforming growth factor-? gene polymorphisms in different phenotypes of sarcoidosis Source: Eur Respir J 2011; 37: 169-175 Year: 2011 Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD Source: Eur Respir J 2006; 28: 556-562 Year: 2006